| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch (gsw)
- наукова стаття, опублікована в січні 2000 (uk)
- article scientifique publié en 2000 (fr)
- im Jahr 2000 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xineru de 2000 (ast)
- artikull shkencor i botuar më 01 janar 2000 (sq)
- scientific article published on 01 January 2000 (en)
- գիտական հոդված հրատարակված 2000 թվականի հունվարի 1-ին (hy)
|
| publication date
| |
| publication date
| |
| author name string
| |
| author name string
| |
| rdfs:label
| - Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules (en)
- Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules (nl)
- Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules (sq)
|
| skos:prefLabel
| - Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules (en)
- Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules (nl)
- Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules (sq)
|
| name
| - Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules (en)
- Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules (nl)
- Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules (sq)
|
| title
| |
| title
| - Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1002/(SICI)1099-1050(200001)9:1<19::AID-HEC487>3.0.CO;2-C
|
| is about
of | |
| is cites work
of | - Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis.
- Increased prevalence of rotavirus among children associated gastroenteritis in Riyadh Saudi Arabia
- The effects and costs of expanding the coverage of immunisation services in developing countries: a systematic literature review
- Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model.
- Genomic diversity of group A rotavirus strains infecting humans in eastern India
- Critical issues in the economic evaluation of interventions against communicable diseases
- Global Illness and Deaths Caused by Rotavirus Disease in Children
- Rotavirus particles can survive storage in ambient tropical temperatures for more than 2 months
- The Pathology of Rotavirus-Associated Deaths, Using New Molecular Diagnostics
- Rotavirus strains circulating in Africa during 1996–1999: emergence of G9 strains and P[6] strains
- Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
- Mathematical models of cervical cancer prevention in Latin America and the Caribbean
- The cost of treatment for child pneumonias and meningitis in the Northern Areas of Pakistan
- Vaccination greatly reduces disease, disability, death and inequity worldwide
- Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.
- Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children
- The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease
- Economic impact of a rotavirus vaccine in Brazil
- Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine
- Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999.
- Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines.
- Economic evaluation of pneumococcal conjugate vaccination in The Gambia
- Characterization of rotavirus strains in a Danish population: high frequency of mixed infections and diversity within the VP4 gene of P[8] strains.
- Characterization of incompletely typed rotavirus strains from Guinea-Bissau: identification of G8 and G9 types and a high frequency of mixed infections.
- Vaccines to prevent pneumonia and improve child survival
- Rotavirus vaccine: a promise for the future.
- Epidemiology of rotavirus and cholera in children aged less than five years in rural Bangladesh
- Future of research into rotavirus vaccine. Cost effectiveness of vaccine is being assessed
- Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves
- Disease burden and related medical costs of rotavirus infections in Taiwan
- [Current framework of biotechnology products according to the available pharmacoeconomic studies]
- Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources
- Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective
- I, 1.Viral causes of gastroenteritis
- Too much of a good thing? When to stop catch-up vaccination
- Time preferences for health in northern Tanzania: an empirical analysis of alternative discounting models
- Expanding global distribution of rotavirus serotype G9: detection in Libya, Kenya, and Cuba
- Emergence of novel human group A rotavirus G12 strains in India
- Rotavirus typing methods and algorithms
- Isolation of human monoclonal antibodies that neutralize human rotavirus
- Characterization of serotype G9 rotavirus strains isolated in the United States and India from 1993 to 2001
- Neonatal rotavirus infection in Belém, northern Brazil: nosocomial transmission of a P[6] G2 strain
- Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse
- Pneumonia's second wind? A case study of the global health network for childhood pneumonia
- Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience
- Cost analysis of care for children admitted to kenyatta national hospital with rotavirus gastroenteritis
- Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis
- A model to estimate the probability of hepatitis B- and Haemophilus influenzae type b-vaccine uptake into national vaccination programs
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)